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In Caenorhabditis elegans, the insulin/IGF-1 DAF-2 receptor controls entry into dauer and longevity. DAF-2 signaling cascade includes
the PI3 kinase homolog AGE-1 and the FOXO transcription factor DAF-16. The DAF-2 pathway is downregulated by DAF-18 which is
encoded by the ortholog of the human tumor suppressor gene PTEN. We have previously shown that, like PTEN, DAF-18 antagonizes the
activity of PI3 kinase/AGE-1. To further explore the role of DAF-18 in the regulation of the insulin pathway, we investigated which tissue(s)
DAF-18 functions in to regulate dauer formation and lifespan. Our data show that complete dauer formation requires daf-18 expression in
several tissues and that the remodeling of dauer tissues depends on both cell autonomous and cell nonautonomous daf-18 function(s).
Conversely, daf-18 expression increases adult lifespan in all individual tissues tested. Furthermore, we show that the role of DAF-18 in dauer
and lifespan control depends on DAF-16 activation, which is regulated by both cell autonomous and cell nonautonomous DAF-18 function(s)
and in a tissue-specific manner. Overall, our data strongly suggest that several tissues act as signaling centers to mediate DAF-18 function and
that DAF-18 could act outside the canonical DAF-2/DAF-16 pathway to regulate dauer and lifespan.
D 2005 Elsevier Inc. All rights reserved.Keywords: daf-18; Dauer; Longevity; Tissue specificity; Insulin pathway; daf-16; C. elegansIntroduction
The insulin and IGF-1 receptor pathways are implicated
in lifespan control of several species. The different
components of the insulin/IGF-1 pathway are conserved
between species and data obtained in human cells suggest
that they act in the same tissues (Barbieri et al., 2003). In
Caenorhabditis elegans, the insulin/IGF-1 DAF-2 receptor
regulates adult lifespan and entry into a specialized enduring
larva stage called dauer. DAF-2 signals to the PI3 kinase
(PI3K) homolog AGE-1 (Dorman et al., 1995; Morris et al.,
1996). AGE-1/PI3K generates phosphatidylinositol 3, 4, 5
triphosphate, or PIP3, responsible for the activation of the
AKT-1, AKT-2, and SGK-1 serine threonine kinases
(Hertweck et al., 2004; Paradis and Ruvkun, 1998).0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.07.010
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by these kinases inhibits DAF-16 function by inducing its
sequestration into the cytoplasm (Henderson and Johnson,
2001; Lee et al., 2001; Lin et al., 2001).
The DAF-2 receptor pathway is downregulated by DAF-
18 which is encoded by the C. elegans ortholog of the
human tumor suppressor gene PTEN (Gil et al., 1999;
Mihaylova et al., 1999; Ogg and Ruvkun, 1998; Rouault et
al., 1999; Solari et al., 2005). We have previously shown
that PTEN can substitute for daf-18 in worms and that DAF-
18, like PTEN, functions as a PIP3 phosphatase. Further-
more, PIP3 is a critical lipid second messenger for dauer and
lifespan regulation. DAF-18 could therefore negatively
regulate the DAF-2 pathway by antagonizing the activity
of PI3K/AGE-1 (Solari et al., 2005).
A body of data reported in the literature raises the
question of the tissue-specific activity of the insulin/IGF-1
pathway components. Results obtained in mammals have
shown that insulin/IGF-1 regulate different physiological286 (2005) 91 – 101
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and Kahn, 2001), while studies on PTEN effectors revealed
that their importance for PTEN function(s) varies depending
on the cell type used (Stiles et al., 2004). In C. elegans,
although genetic interaction studies support the hypothesis
that the different effectors of the insulin/IGF-1 pathway
could act together in the same cell types, data on the tissue-
specific expression/function relationship of DAF-2 (Wol-
kow et al., 2000) and DAF-16 (Libina et al., 2003) suggest
that the sites of action of these two proteins may not
completely overlap for lifespan control.
To further explore the role of DAF-18 in the insulin
pathway regulation, we investigated which tissue(s) DAF-
18 functions in to regulate dauer and lifespan. Here we show
that daf-18 expression in all individual tissues tested
(muscles, intestine, neuronal tissues, and seam cells) can
significantly extend the lifespan of daf-18(); daf-2()
animals. Conversely, rescue of the dauer phenotype requires
daf-18 expression in several tissues. Interestingly, even
though single tissue daf-18 expression can induce growth
arrest, it does not allow complete remodeling of dauer
tissues. Overall, our data strongly suggest that daf-18 acts in
both a cell autonomous and cell nonautonomous manner for
dauer and lifespan regulation. Moreover, we show that
DAF-18 acts via DAF-16 not only in signaling tissues, in
which DAF-18 is essential for DAF-2-dependent DAF-16
nuclear translocation, but also in distant target tissues.
Collectively, our study shows that rescue of the dauer and
lifespan phenotypes upon daf-18 tissue-specific expression
is not an all-or-none phenomenon. This is in contrast to
results from studies on the tissue-specific functions of daf-2
(Apfeld and Kenyon, 1998; Wolkow et al., 2000), thus
revealing branching of the DAF-2 pathway and cross talk of
DAF-18 with other pathways in the regulation of lifespan
and dauer.Materials and methods
Strains
Strains used were as follows: wild-type N2 bristol, daf-
2(e1370) III, daf-18(mg198) IV, and daf-2(e1370); daf-
18(mg198). daf-18(mg198) mutants, kindly provided by G.
Ruvkun, are dauer defective and short lived (Solari et al.,
2005).
Constructs
Pdaf-18::gfp (pFS1) and Pdaf-18::daf-18cDNA (pFS3)
plasmids were obtained as described in Solari et al., 2005.
Punc-119::gfp and Punc-119::daf-18 cDNA vectors were
generated by inserting a HindIII/PstI or blunt-ended
HindIII/PstI fragment from pBY103 (Maduro and Pilgrim,
1995) into, respectively, HindIII/PstI-digested pPD95.75
(gift from Andy Fire) or XbaI/SmaI-digested pFS3. Pnhr-72::gfp and Pnhr-72::daf-18 cDNA plasmids were con-
structed by insertion of a blunt-ended PstI/BamHI or SphI/
SmaI fragment of pPD95.77-nhr-72p (Miyabayashi et al.,
1999) into, respectively, blunt-ended XbaI/BamHI-digested
pFS1 or SphI/SmaI-digested pFS3. Pges-1::gfp and Pges-
1::daf-18 cDNA vectors were generated by cloning a XhoI/
BamHI or XhoI/SmaI fragment of pJM16 (Aamodt et al.,
1991) into, respectively, SalI/BamHI sites of pPD95.75 or
SalI/SmaI sites of pFS3. To generate Pelt-7::gfp and Pelt-
7::daf-18 cDNA vectors, the SphI/BamHI or SphI/XmaI
fragment of pKS71 (kindly provided by Joel Rothman,
University of California, Santa Barbara) was cloned into,
respectively, SphI/BamHI sites of pPD95.75 or SphI/XmaI
sites of pFS3. Punc-54::gfp and PEunc-54::gfp constructs
were generated by inserting the PstI/KpnI and HindIII/KpnI
fragments of pPD30.38 (gift from Andy Fire (Okkema et al.,
1993), respectively, into PstI/KpnI and HindIII/KpnI sites
of pPD95.75. The Punc-54::daf-18 cDNA and PEunc-
54::daf-18 cDNA vectors were obtained by inserting the
SphI/KpnI-blunt-ended and SphI-blunt-ended/SmaI frag-
ments of pPD30.38 (gift from Andy Fire) into, respectively,
SphI/SmaI and HindIII-blunt-ended/EaeI sites of pFS3.
Transgenic lines
In order to test the rescue of dauer and lifespan
phenotypes of simple mutants daf-18 (mg198), two inde-
pendent lines were generated by co-injection of 20 ng/Al of
pFS1 and pFS3 constructs together with pRF4(rol-6) as an
injection marker at 100 ng/Al into daf-18 (mg198) mutants
and then integrated by UV irradiation (0.012 J/cm2). Two
independent integrated transgenic lines have been tested in
dauer and lifespan assays.
For each tissue-specific promoter, the corresponding
transgenes encoding daf-18 cDNA and gfp were co-injected
at 20 ng/Al together with pRF4 (rol-6) at 100 ng/Al into daf-
2 (e1370); daf-18 (mg198) mutants to generate several
independent transgenic lines. For lifespan tests, dauer
assays, and RNAi experiments (see below), at least two
independent lines have been analyzed for each promoter
except for unc-54 promoter.
Tissue-specific GFP expression was confirmed using
Nomarski and fluorescence microscopy (Fig. S2). We
observed the expected GFP pattern for all promoters in L1
and adults at 25-C except for unc-119 promoter. During the
transition from L1 to dauer, daf-18 (mg198); daf-2 (e1370);
ExPunc-119::daf-18 cDNA animals showed GFP staining
of neurons but also of the hypodermis. The GFP pattern was
restricted to neurons in all other larval stages including in
dauers and adults.
DAF-16::GFP expressing strains were obtained by co-
injecting transgenes encoding daf-18 cDNA under the
control of tissue-specific promoter and Pdaf-16::daf-
16a2cDNA::GFP (pGP30, Henderson and Johnson, 2001)
at 20 ng/Al for each construct together with pRF4 (rol-6) at
100 ng/Al into daf-2 (e1370); daf-18 (mg198) mutants. For
Fig. 1. Expression of Pdaf-18::daf-18 cDNA in daf-18 (mg198) mutants
rescues their short-lived phenotype. The percentage of live animals was
plotted as a function of time. daf-18 (mg198) mutants have a reduced
lifespan compared to wild-type (mean lifespans: 8.2 T 0.1 and 10.6 T 0.3
days, respectively, at 25-C). daf-18 (mg198) mutants containing Pdaf-
18::daf-18 as an integrated array (see Materials and methods) have a similar
lifespan (mean lifespan: 11.2 T 0.2 days) to wild-type.
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two to three independent transgenic lines have been
analyzed for each promoter.
Lifespan assays
Lifespan assays were performed at 25-C on growth
medium (NGM) plates containing 10 AM 5-fluorodeoxy-
uracile (5-FU 250 mg/5 ml, Roche) to prevent growth of
progeny. Animals were grown on regular NGM plates at
15-C until reaching the L4 stage and then transferred to 5-
FU-containing plates at 25-C. The day of the shift is
counted as day 0 in the adult lifespan assay. Animals were
scored as dead when they ceased moving and responding to
prodding.
Dauer assays
The dauer phenotype was scored essentially as described
(Gottlieb and Ruvkun, 1994). L4 animals were transferred
from 15 to 25-C and then removed after 24 h. The progeny
was scored for dauer formation 72 h later. Growth-arrested
animals were observed under Nomarski microscopy and
scored for dauer criteria: radial constriction of the body,
elongation of the pharynx, presence of dauer alae, and
developmentally arrested gonad. In order to examine lipidic
intestinal granules accumulation, dauer assays were also
performed on Nile Red (N-1142 Molecular Probes) con-
taining plates (100 Al of 0.05 Ag/ml Nile Red in 1
phosphate buffered saline added on top of NGM plates
already seeded with bacteria). Growth-arrested worms were
scored for fat content by fluorescence microscopy (560–590
nm filter).
daf-18 (mg198); daf-2 (e1370) double mutants and daf-2
(e1370) single mutants were used as negative and positive
controls, respectively.
RNAi experiments
Bacterial feeding RNAi experiments were carried out
essentially as described previously (Kamath et al., 2001).
Briefly, single colonies of HT115 bacteria containing
plasmids of interest were first grown overnight in LB with
100 Ag/ml ampicillin and 12.5 Ag/ml tetracyclin and then for
8 h in LB with 100 Ag/ml ampicillin. Bacteria were seeded
directly onto NGM plates containing 1 mM IPTG and 25
Ag/ml carbenicillin. Clones used, R13H8.1 (daf-16) and
F15B3.1 (dys-1), have been purchased from UK MRC
Human Genome Mapping Project Resource Centre, Hinx-
ton, Cambridge.
Observation of DAF-16::GFP subcellular localization
The subcellular localization of the DAF-16::GFP protein
in transgenic animals was analyzed by fluorescence micro-
scopy under a GFP filter. About 10 worms were mounted bypad (2% agarose with 5 mM tetramisole) to avoid DAF-
16::GFP translocation due to stress (Lin et al., 2001). Two to
three independent transgenic lines for each promoter have
been analyzed.Results
The daf-18 promoter is active in many tissues throughout
development
The daf-18 promoter (Pdaf-18) was isolated as described
in Solari et al., 2005. Expression of daf-18 cDNA under the
control of Pdaf-18 rescued the dauer defective and short
lifespan phenotypes of daf-18 (mg198) null mutants (data
not shown and Fig. 1). These data indicate that the cloned
promoter region contains all regulatory sequences required
for DAF-18 control of dauer and lifespan. We then
examined the pattern of expression of a reporter gene
encoding the green fluorescent protein (GFP) under the
control of Pdaf-18. We observed widespread GFP expres-
sion in embryos from the bean stage onwards. During larval
development, GFP expression revealed that the daf-18
promoter was active in many if not all tissues, including
the intestine, neurons, body wall muscles, seam cells and
hypodermis, with elevated GFP levels in a few head neurons
and in the intestine from L1 to adult stage at 15-C and 25-C
(Fig. 2A).
Under favorable growth conditions, C. elegans pro-
gresses through four larval stages (L1–L4) before becoming
an adult. Less than favorable conditions (starvation, over-
crowding, or thermal stress) drive L1 larva into a specialized
larval stage called dauer (enduring). The dauer larva is
reversibly arrested, does not feed, is resistant to harsh
environmental conditions, is long-lived, and can be distin-
guished from a growing larva by specific morphological
features (Riddle, 1997). In order to monitor GFP expression
during dauer entry, we generated transgenic animals
Fig. 2. Pdaf-18::gfp expression pattern. Pdaf-18::gfp expression pattern was similar in the different genetic backgrounds tested [e.g., N2 wild-type or daf-18
(mg198); ExPdaf-18::daf-18 cDNA or daf-18 (mg198); daf-2 (e1370); ExPdaf-18::daf-18 cDNA]. (A) GFP is broadly expressed in all larval stages as
illustrated here in daf-18 (mg198); InsPdaf-18::daf-18 cDNA, Pdaf-18::gfp adults. (B) Broad up-regulation of GFP levels in daf-18 (mg198); daf-2 (e1370);
ExPdaf-18::daf-18 cDNA, Pdaf-18::gfp in L1 larvae induced to enter the dauer stage at 25-C (confirmed by quantification of GFP fluorescence in L1 and
L2D, data not shown). (C) GFP is highly expressed in the ventral and dorsal nerve cords of daf-18 (mg198); daf-2 (e1370), ExPdaf-18::daf-18 cDNA, Pdaf-
18::gfp dauer larva at 25-C (vcn, ventral cord neurons). Scale bars: 200 Am for panel A and 90 Am for panels B and C.
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(e1370) double mutants. Thermosensitive daf-2 (e1370)
mutants constitutively enter the dauer stage at the restrictive
temperature of 25-C, while the daf-18 (mg198) null
mutation suppresses the constitutive dauer phenotype of
daf-2 (e1370) mutants. Expression of the Pdaf-18:: daf-18
cDNA in daf-18 (mg198); daf-2 (e1370) mutants (Pdaf-18
strains) recapitulates the dauer constitutive phenotype of
daf-2 (e1370) single mutants (Figs. 3A and B and Solari et
al., 2005). When we examined the GFP expression in
worms induced to enter the dauer stage at 25-C, we
observed a wide up-regulation of GFP levels in many if
not all tissues during the transition between L1 and pre-
dauer L2D stage (Fig. 2B). Once dauer tissues were fully
remodeled, high GFP levels were then limited to head
neurons and ventral and dorsal nerve cords (Fig. 2C). Thus,
high daf-18 expression in nerve cords may be important for
dauer maintenance. Overall, these data suggest that DAF-18
is broadly expressed, similarly to AKT-1, PDK-1, and DAF-
16 (Ogg et al., 1997; Paradis et al., 1999; Paradis and
Ruvkun, 1998).
Complete dauer formation requires daf-18 expression in
more than one tissue
To assess the importance of daf-18 expression in
individual tissues on dauer formation, we generated trans-
genes to drive daf-18 cDNA expression specifically in body
wall muscles (unc-54 promoter, Punc-54, Okkema et al.,
1993), neurons (unc-119 promoter, Punc-119, Maduro and
Pilgrim, 1995), intestinal cells (ges-1 promoter, Pges-1,
Aamodt et al., 1991), or lateral epidermal cells called seam
cells (nhr-72 promoter, Pnhr-72, Miyabayashi et al., 1999)
of daf-2(e1370); daf-18 (mg198) double mutants. We then
asked whether daf-18 expression in these different tissues
was sufficient to recapitulate the dauer constitutive pheno-
type of daf-2 (e1370) single mutants. Entry into dauer is
characterized by growth arrest and remodeling of different
tissues that allows the discrimination of dauer from a L3
larva stage and includes: radial constriction of the body, anelongated pharynx, the accumulation of lipid granules in the
intestine and the formation of protruding ridges of the
cuticle, termed alae, which are generated by the seam cells
(see Materials and methods and Fig. S1).
Expression of daf-18 cDNA under the control of its
promoter was sufficient to restore full dauer formation, with
extensive tissue remodeling similar to that observed in daf-2
(e1370) single mutants (Solari et al., 2005 and Fig. 3). The
expression of daf-18 in individual tissues of daf-18 (mg198);
daf-2 (e1370) mutants was sufficient to induce a high
percentage of growth-arrested animals, except when daf-18
was expressed in body wall muscles. We then looked at the
remodeling of different tissues in the arrested larvae. We
observed the induction of lipid accumulation in the intestine
when daf-18 was expressed in all individual tissues tested.
Alae formation was also observed with high penetrance for
all examined promoters except in Punc-54 animals. Con-
versely, radial constriction and pharynx extension were
highly penetrant only in Punc-119 animals, although
pharynx elongation was observed for only 57% of Punc-
119 animals as compared to 98% of Pdaf-18 animals.
Finally, none of the transgenic strains expressing daf-18 in
individual tissues restored the highly penetrant gonadal
developmental arrest which is observed in Pdaf-18 animals.
These observations reveal the existence of tissue-specific
DAF-18 activity in the regulation of dauer formation.
Furthermore, our results show that daf-18 must be expressed
in several tissues for the formation of fully remodeled dauers.
Interestingly, lipid accumulation in the intestine or alae
formation cannot only be induced when daf-18 is expressed,
respectively, in intestinal or seam cells, but also when daf-18
is expressed in distant tissues. Thus, these results show that
DAF-18 potentially acts both cell autonomously and cell
nonautonomously to regulate dauer formation.
Higher tissue-specific daf-18 expression does not result in
full dauer formation
As suggested for daf-2 (Apfeld and Kenyon, 1998;
Wolkow et al., 2000), daf-18 expression could control the
Fig. 3. Growth arrest and tissues remodeling phenotypes of daf-18 (mg198); daf-2 (e1370) mutants with tissue-specific daf-18 expression. The different
phenotypes were analyzed as described in Materials and methods (see Fig. S1 for illustration of dauer criteria). At 25-C, double mutants did not show any of
dauer morphological characteristics. daf-2 (e1370) single mutants (A, 74 animals scored) were used as positive control. The numbers of animals scored for
each phenotype were, respectively, for Pdaf-18 (B), Punc-119 (C), Pnhr-72 (D), Pges-1 (E), Pelt-7 (F), Punc-54 (G), and EPunc-54 (H) transgenic strains:
333, 166, 704, 448, 1523, 497, and 492 for growth arrest; 97, 200, 156, 254, 67, 45, and 92 for the presence of an alae, radial constriction, pharynx
elongation, and gonad size; 46, 95, 79, 86, 22, 18, and 32 for accumulation of Nile Red positive lipid granules in the intestine (high intestinal fat level, see
Materials and methods and Fig. S1).
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remodeling of different tissues. According to this hypo-
thesis, the secondary signal may need to reach a certain
threshold in order to induce tissues remodeling. Higher daf-
18 expression levels would therefore increase the percent-
age of worms with remodeled tissues. To test this
hypothesis, we asked whether higher daf-18 expression in
the intestine or in body wall muscles would result in a
higher percentage of dauer rescue. For this purpose, we usedelt-7 (K. Strohmaier and J. Rothman, unpublished) and unc-
54 enhancer promoters that drive stronger GFP expression
in the intestine (as compared to ges-1 promoter) and in body
wall muscles (as compared to unc-54 promoter), respec-
tively (Fig. S2, C to F). Higher expression in the intestine or
in muscles did not significantly increase the extent of overall
tissue remodeling (Figs. 3E to H). Thus, dauer control by
daf-18 seems to depend primarily on the tissue where daf-
18 is expressed rather than on its level of expression.
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significantly extend lifespan
Previous studies have shown that dauer and lifespan
regulation are separable processes and require different
tissue-specific activities of both DAF-2 and DAF-16. We
thus asked whether daf-18 expression in a single tissue
would be sufficient to increase the lifespan of daf-18
(mg198); daf-2 (e1370) animals. The expression of daf-18
under the control of its own promoter increased the mean
lifespan of daf-18 (mg198); daf-2 (e1370) mutant animals
from 11.7 to 17.4 days (Table 1). We found that expressing
daf-18 under the control of unc-119, ges-1, nhr-72, or unc-
54 promoter is sufficient to significantly extend the lifespan
of double mutants.
Furthermore, we reproducibly observed that Punc-119
and Pnhr-72 animals live longer compared to Pges-1 and
Punc-54 animals and their lifespan is similar to worms
carrying a transgene driven by the endogenous daf-18
promoter (no statistical difference between lifespans, see
Table 1). Moreover, increasing expression levels in the
intestine (Pelt-7 versus Pges-1) or muscles (EPunc-54 versus
Punc-54) did not result in a further increase in lifespan (Table
1), indicating that the level of daf-18 expression in these
tissues is not a limiting factor. Overall, these data show that
several tissues have the potential to mediate the role of DAF-
18 in lifespan regulation and strongly suggest that the
function of DAF-18 relies on tissue-specific activities.
Dauer entry and lifespan extension upon tissue-specific
expression of daf-18 depends on daf-16 function
Genetic approaches have established that DAF-16 is the
major target of DAF-2 signaling since mutation of daf-16
completely suppressed the constitutive dauer phenotype and
abolished lifespan extension of daf-2() mutants (Lin et al.,
1997). Recent data have shown that daf-16 expression in
muscles or intestinal cells of daf-16 (); daf-2 () mutants
does not recapitulate the daf-2 () dauer phenotype whereas
daf-16 neuronal expression is sufficient to induce dauerTable 1
Adult lifespan of animals with tissue-specific daf-18 expression
Background Transgenesa Mean lifespan T SE
(days)
daf-18 (mg198);
daf-2 (e1370)
Noneb 11.7 T 0.2
ExPdaf-18::daf-18cDNA 17.4 T 0.3
ExPunc-119::daf-18cDNA 16.7 T 0.6
ExPnhr-72::daf-18cDNA 16.5 T 0.3
ExPges-1::daf-18cDNA 15.6 T 0.4
ExPelt-7::daf-18cDNA 15.9 T 0.3
ExPunc-54::daf-18cDNA 15.5 T 0.2
ExEPunc-54::daf-18cDNA 14.7 T 0.2
a All strains carried the co-injection marker rol-6 and transgenes as extrachromosom
daf-18 (mg198); daf-2 (e1370); Exrol-6 mutants. Data were summed because they
comparisons of lifespan using Student’s t test d between strains with tissue-specific
strains with tissue-specific daf-18 expression and ExPdaf-18::daf-18cDNA strainentry. Conversely, DAF-16 activity in the intestine was
found to be more important than in neurons for regulating
lifespan (Libina et al., 2003).
To test whether daf-16 is required for dauer rescue when
daf-18 is expressed in single tissues, we inactivated daf-16
function by RNAi. While 100% of daf-18 (mg198); daf-2
(e1370) mutants expressing daf-18 under the control of its
own promoter entered the dauer stage when fed with control
bacteria, only 65% arrested at the dauer stage when grown on
daf-16 RNAi plates (Fig. 4). This partial inhibition is most
probably due to incomplete inactivation of daf-16 by RNAi
since daf-16 RNAi was unable to completely suppress the
constitutive dauer phenotype of daf-2(1370) control mutants
(Fig. 4). Inhibition of dauer entry by daf-16 RNAi was
similar for all transgenic lines expressing daf-18 in distinct
tissues. Overall, these results indicate that DAF-16 function
is critical for dauer rescue, independent of the tissue in which
daf-18 is expressed, whether daf-18 is expressed in neurons
(in which daf-16 expression is sufficient to regulate dauer;
Libina et al., 2003) or in other tissues.
Similar to daf-16 null mutant (Lin et al., 2001), wild-type
worms fed with daf-16 RNAi live 20% less compared to
wild-type worms cultured on control plates (Table 2).
Furthermore, daf-16 RNAi recapitulated wild-type lifespan
of long-lived daf-2 (e1370) mutants. Thus, in both cases,
daf-16 RNAi efficiently reduces DAF-16 activity for
lifespan regulation. daf-16 RNAi inhibits lifespan extension
of daf-18 (mg198); daf-2 (e1370) mutants by daf-18,
whether daf-18 is expressed under the control of daf-18;
unc-119; nhr-72; ges-1; unc-54 or unc-54 enhancer
promoters (Table 2). Furthermore, lifespan of double
mutants daf-18 (mg198); daf-2 (e1370) is not significantly
affected by daf-16 RNAi, indicating that the reduction of
lifespan observed in daf-18 expressing lines depends
primarily on DAF-18-dependent DAF-16 activation. These
results show that DAF-16 is essential for the DAF-18-
dependent lifespan increase, whether DAF-18 is expressed
in the intestine (in which daf-16 expression recapitulates
most of its activity for lifespan regulation; Libina et al.,
2003) or in other tissues.Mc No. animals P value against
controld
P value against
specific groupe
301
579 <1.00E09
181 <1.00E09 0.31
211 <1.00E09 0.063
209 <1.00E09 <1.00E03
182 <1.00E09 <1.00E03
194 <1.00E09 <1.00E06
200 <1.00E09 <1.00E09
al arrays (Ex). b Data include results for daf-18 (mg198); daf-2 (e1370) and
were consistent. c SEM: standard error of the mean. P values correspond to
daf-18 expression and daf-18 (mg198); daf-2 (e1370) mutants or e between
s.
Fig. 4. Effect of daf-16 RNAi on the growth arrest phenotype of daf-18
(mg198); daf-2 (e1370) mutants with tissue-specific daf-18 expression. The
percentage of growth arrest inhibition represents the difference between the
percentages of worms arrested on dys-1 RNAi control plates and on daf-16
RNAi plates at 25-C. The numbers of worms scored, respectively, on dys-1
RNAi and daf-16 RNAi plates are 560 and 385 for Pdaf-18, 459 and 332
for Punc-119, 425 and 263 for Pnhr-72, 410 and 416 for Pges-1, 410 and
416 for Pelt-7, 361 and 253 for Punc-54, and 123 and 95 for EPunc-54.
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Our results regarding dauer rescue upon expression of
daf-18 revealed cross communication between tissues.
Thus, dauer regulation by daf-18 must involve the gene-
ration of a secondary signal from signaling tissue(s) in
which daf-18 is expressed, that is responsible for the
remodeling of target tissues. Since daf-16 is required for
dauer entry upon daf-18 expression, DAF-16 function may
be required in the signaling tissue, or in target tissues, or in
both.
To test this hypothesis, we examined the subcellular
localization of a DAF-16::GFP fusion protein in transgenic
lines expressing both daf-18 in a single tissue and Pdaf-
16::daf-16::gfp in different tissues (see Materials and
methods). It has been shown that when the insulin/IGF-1
pathway is activated, DAF-16::GFP is sequestrated in the
cytoplasm and thus inactivated. Conversely, in the absenceTable 2
Effect of daf-16 RNAi on lifespan of daf-18 (mg198); daf-2 (e1370) mutants wi
Genotype Mean lifespan T SE
Background Transgenea
on control RNAic
Wild-type N2 None 12.2 T 0.4
daf-2 (e1370) None 19.8 T 1.3
daf-18 (mg198);
daf-2 (e1370)
None 10.0 T 0.5
ExPdaf-18::daf-18cDNA 16.7 T 0.5
ExPunc-119::daf-18cDNA 14.9 T 0.5
ExPnhr-72::daf-18cDNA 13.6 T 0.4
ExPges-1::daf-18cDNA 14.5 T 0.4
ExPunc-54::daf-18cDNA 13.9 T 0.4
ExEPunc-54::daf-18cDNA 13.8 T 0.5
a All strains carried the co-injection marker rol-6 and transgenes as extrachromoso
was grown on control plates (seeded with HT115 bacteria containing the empty
dMean lifespans represent the average between two independent transgenic linesof DAF-2 activation, DAF-16::GFP is translocated to the
nucleus where it can then fulfill its role as a transcription
factor (Henderson and Johnson, 2001; Lee et al., 2001; Lin
et al., 2001). In agreement with this model, DAF-16::GFP is
essentially cytoplasmic in the intestine, body wall muscles,
seam cells, and neurons in double mutants daf-18 (mg198);
daf-2 (e1370) (Figs. 5 and S3).
Pdaf-18 animals show an enrichment of DAF-16::GFP in
nuclei of the intestine, seam cells, and body wall muscles.
Furthermore, DAF-16::GFP localization is principally
nuclear in neurons (Figs. 5 and S3). The increase in nuclear
DAF-16::GFP is also observed in all tissues when daf-18 is
expressed under the control of all other promoters tested, but
the translocation pattern varies depending on the tissue in
which daf-18 is expressed and according to the target tissue
considered. The DAF-16::GFP translocation pattern is very
similar between Pdaf-18, Punc-119, and Pnhr-72 animals.
Conversely, when daf-18 is expressed in body wall muscles
or in the intestine, the level of DAF-16::GFP nuclear
translocation is globally much lower and DAF-16::GFP
remains essentially cytoplasmic in neurons when daf-18 is
expressed in the intestine (Fig. 5).
Overall, our results show that daf-18 expression in a
single tissue is sufficient to induce DAF-16 nuclear trans-
location in the same tissue, but also in distant tissues.
Furthermore, our data suggest that, upon daf-18 expression,
tissues differ in their competence for inducing DAF-16
nuclear translocation in both signaling and target tissues.Discussion
Genetic studies have shown that mutation of daf-18
suppresses the dauer and lifespan phenotypes of daf-2
mutants and they predict that DAF-18 acts downstream of
AGE-1 and upstream of AKT-1, AKT-2, and SGK-1 kinases
that regulate the DAF-16 FOXO transcription factor. Here,
we show that DAF-18 acts in several tissues and in a tissue-
specific manner to regulate dauer entry and lifespan.
Furthermore, our data suggest that DAF-18 could also actth tissue-specific daf-18 expression
Mb No. Mean lifespan T SEM No.
(days) animals on daf-16 RNAid (days) animals
101 9.7 T 0.4 107
49 12.2 T 0.3 48
102 9.8 T 0.3 101
94 11.7 T 0.3 92
92 10.1 T 0.3 90
90 10.5 T 0.4 80
89 10.7 T 0.3 92
44 10.9 T 0.4 43
94 10.9 T 0.4 93
mal arrays (Ex). bSEM: standard error of the mean. In all trials, each strain
vector) c and on HT115 bacteria producing daf-16 double-stranded RNA.
except for Punc-54.
Fig. 5. DAF-16::GFP subcellular localization in daf-18 (mg198); daf-2 (e1370) mutants with tissue-specific daf-18 expression. The overall level of GFP did
not vary significantly between strains. DAF-16::GFP subcellular localization was examined in the intestine, the seam cells, the body wall muscles, and in
neurons of animals maintained at 15-C. The bars give the percentage of animals with essentially nuclear (red), nuclear and cytoplasmic (orange), or mainly
cytoplasmic (yellow) GFP staining in cells of the corresponding tissue. The number of worms examined are 289, 94, 215, 173, 192, and 109, respectively, for
daf-18 (mg198); daf-2 (e1370), Pdaf-18, Punc-119, Pnhr-72, Pelt-7, and Punc-54 animals.
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both physiological processes.
DAF-18 functions both cell autonomously and
nonautonomously to regulate entry into dauer
Our results show that daf-18 expression in single tissues
is sufficient to induce a high percentage of growth arrest.
However, tissues of arrested animals are not fully remodeled.
We therefore conclude that daf-18 expression in all single
tissue tested is not sufficient to induce full dauer formation
and that expression of daf-18 in more than one tissue isnecessary to obtain full dauer entry. Furthermore, this model
could account for the wide up-regulation of pdaf-18::GFP
expression observed during dauer entry (Fig. 2B).
Interestingly, a given tissue can adopt a dauer morphol-
ogy whether daf-18 is expressed in this tissue or not, thus
indicating the existence of (a) secondary signal(s) respon-
sible for this effect. One limitation of tissue-specific strategy
relates to the strength of the promoter used, meaning that
higher daf-18 expression could induce stronger secondary
signaling. This is probably not the case since increasing
expression levels in the intestine or in body wall muscles did
not improve dauer rescue (Figs. 3 and S2). Overall, our
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requires its expression in different tissues and that these
tissues differ in their potential to induce remodeling of target
tissues. We favor a model in which daf-18 functions in both
a cell autonomous and cell nonautonomous manner in
several tissues to allow complete remodeling of dauer
tissues.
Different tissues are competent for mediating DAF-18
activity in lifespan extension
Wolkow et al. (2000) have reported that daf-2 expression
in neurons alone is sufficient to regulate adult lifespan. In
agreement with these data, our results suggest that daf-18
expression in neurons is more efficient for daf-2-dependent
lifespan extension than its expression in the intestine or in
body wall muscles (Table 1). Furthermore, hypodermis
expression of DAF-18 is also able to completely rescue
lifespan, whereas muscle or intestine expression only
partially rescues lifespan.
Overall, our data do not favor a model in which only one
tissue acts as a signaling center to influence longevity of the
whole organism, as proposed for daf-2 function (Wolkow et
al., 2000), and sustain the hypothesis that DAF-18
expression can have a beneficial effect on adult lifespan in
multiple tissues.
The potential of restricted daf-18 expression to regulate
lifespan of the whole organism suggests that daf-18 could
act in a cell nonautonomous manner. The current lack of
available aging markers does not allow the assessment of
aging in different tissues to test this hypothesis. However,
on the basis of DAF-16 regulation by DAF-18 (see below),
we favor a model where daf-18 would act in both a cell
autonomous and cell nonautonomous manner.
DAF-16 is essential for dauer and lifespan rescue upon
daf-18 tissue-specific expression
DAF-16 is known to be the major output of DAF-2
signaling since epistatic experiments have shown that daf-
16 mutation suppresses both dauer and lifespan phenotypes
of daf-2 mutants (Lin et al., 1997). Our results support a
model in which daf-18 acts in a daf-16-dependent manner to
regulate dauer and lifespan regardless of the tissue in which
daf-18 is expressed.
daf-16 RNAi partially suppressed the dauer phenotype of
all transgenic strains but also of daf-2 (e1370) control
mutants, suggesting that RNAi does not completely
eliminate daf-16 activity. Interestingly, we observed main-
tenance of DAF-16::GFP expression in neurons after daf-16
RNAi in all transgenic strains. While the partial inhibition of
dauer entry by daf-16 RNAi might indicate that daf-16
expression in neurons is important for dauer control,
expression of daf-16 is also clearly required in other tissues.
daf-16 RNAi completely abrogates lifespan extension in
the different transgenic lines suggesting that daf-16 is themajor target of daf-18 in the regulation of lifespan. This was
observed regardless of whether daf-18 was expressed in
body wall muscles, seam cells, intestine, or neurons.
Furthermore, we still observed DAF-16::GFP staining in
neurons of adults fed with daf-16 RNAi, thus suggesting
that daf-16 expression within the nervous system is not
critical for lifespan regulation via daf-18.
Overall, our results suggest that DAF-16 is an important
effector for DAF-18 function in neurons, intestine, seam
cells, and body wall muscles for both dauer and lifespan
regulation.
DAF-16 is an effector of DAF-18 not only in signaling
tissues but also in target tissues
In order to further investigate the cell autonomous and
cell nonautonomous functions of DAF-18 and their relation-
ship with DAF-16 activity, we examined the translocation
pattern of DAF-16::GFP. Although DAF-16 is nuclear in
daf-2(e1370) mutants (Henderson and Johnson, 2001; Lee
et al., 2001; Lin et al., 2001), DAF-16 is essentially
cytoplasmic in daf-18 (); daf-2 () double mutants,
regardless of whether animals are maintained at the
permissive or restrictive temperature for the daf-2 (e1370)
mutation (this study and Lin et al., 2001). This demonstrates
that DAF-18 is a critical effector for DAF-2-dependent
nuclear translocation of DAF-16.
Our data show that daf-18 expression in an individual
tissue is sufficient to induce DAF-16 nuclear translocation
not only in the cells of that tissue but also in distant tissues.
Libina et al. (2003) have reported that overexpression of
DAF-16 in a single tissue of wild-type animals is sufficient
to activate the expression of sod-3, a transcriptional target
of DAF-16, in other tissues. We thus propose that the
nuclear translocation of DAF-16 upon daf-18 expression in
one tissue might be responsible for the generation of a
secondary signal leading to DAF-16 activation in other
target tissues.
Furthermore, our data show that DAF-16 can be activated
in target tissues of daf-18 (mg198); daf-2 (e1370) mutants
which do not express DAF-18. DAF-16 activation in target
tissues may thus result from downregulation of the DAF-2
pathway upstream of DAF-18, for example, by inactivation
of the DAF-2 receptor. Interestingly, ins-18 encodes a
potential antagonistic ligand of DAF-2 receptor (Pierce et
al., 2001) and is a transcriptional target of DAF-16
(Murphy et al., 2003). According to our model, daf-18
expression in signaling tissues could induce ins-18 tran-
scriptional activation by DAF-16. INS-18 would then act as
a secondary signal to inhibit DAF-2 in target tissues. DAF-
2 inhibition in these tissues would then lead to DAF-16
nuclear translocation.
Overall, although our results do not allow us to elucidate
the functional significance of DAF-16 nuclear translocation
in each tissue, the essential role of daf-16 for dauer and
lifespan rescue upon daf-18 expression in different individ-
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both the cell autonomous and cell nonautonomous function
of DAF-18.
Relationship between daf-18 function and tissue-specific
activities of daf-16 and daf-2 for dauer and lifespan control
Study of the tissue-specific activity of DAF-16 has shown
that daf-16 expression in neurons, under the control of unc-
119 promoter, rescues the dauer phenotype of daf-16 ();
daf-2 () double mutants whereas all animals develop into
adults when daf-16 is expressed in muscles or in the
intestine (Libina et al., 2003). We indeed observed DAF-16
nuclear translocation in neurons for all transgenic lines
(Figs. 5 and S4). More strikingly, DAF-16 is exclusively
cytoplasmic in the nervous system of worms that do not
arrest in dauer (Fig. S5). Thus, in agreement with the results
of Libina et al., our observations could reflect the need for
daf-16 activation in neurons. This model would also account
for the partial inhibition of dauer entry upon daf-16 RNAi
which is associated with the persistence of DAF-16::GFP in
neurons as discussed above. However, DAF-16 nuclear
translocation in neurons is not sufficient to induce dauer
entry, since DAF-16 nuclear translocation is also observed at
15-C in Pdaf-18 animals which do not enter the dauer stage
(Fig. 5). Thus dauer control by DAF-18 must require its
activity in other tissues to induce full activation of DAF-16
in neurons.
Libina and colleagues (Libina et al., 2003) have shown
that expression of daf-16 extends the lifespan of daf-16 ();
daf-2 () mutants more efficiently when it is expressed in
the intestine than in neurons and it does not affect lifespan at
all when it is expressed in the muscle. Our results show that
expression of daf-18 in any single tissue tested is sufficient
to significantly extend lifespan and that DAF-18 function is
DAF-16 dependent whether daf-18 is expressed in the
intestine, neurons, muscles, or seam cells. One hypothesis
that could explain this discrepancy is that DAF-16 activity
in responding tissues [absent in double mutants daf-16 ();
daf-2 ()] is essential for lifespan extension upon daf-16
expression in muscle, but is less critical when daf-16 is
expressed in neurons and dispensable when daf-16 is
expressed in the intestine. In agreement with this hypoth-
esis, daf-18 expression in the intestine is much less efficient
at inducing DAF-16 nuclear translocation in other tissues as
compared to strains expressing daf-18 in neurons or muscles
(Fig. S4, adults at 25-C). Finally, DAF-16 expression is
probably required outside the intestine since its expression
in this tissue does not fully rescue the lifespan phenotype of
daf-16 (); daf-2 () mutants (Libina et al., 2003). Based
on these data, we propose that DAF-16 mediates DAF-18
function in the intestine but also in other tissues for the
regulation of lifespan. Additionally, although previous
studies did not assess DAF-2 and DAF-16 activities in
seam cells, our data point towards their involvement in
lifespan and dauer control by DAF-18.Study of the tissue-specific activities of daf-2 in
lifespan regulation (Wolkow et al., 2000) showed that
daf-2 expression under the control of unc-119 promoter
reduced the lifespan of daf-2 mutants whereas expression
in muscles or intestine under the control of unc-54 and
ges-1 promoters did not have any significant effect on their
lifespan. In addition, daf-2 expression in those tissues did
not inhibit dauer entry, with daf-2 (e1370) worms
remaining growth arrested with high levels of intestinal
fat. Our data suggest that the function of daf-18 in muscles
and intestine may not rely on daf-2 receptor regulation in
those tissues to control both dauer and lifespan. Interest-
ingly, in contrast to daf-2, the expression of age-1 (the C.
elegans ortholog of the catalytic subunit of the human PI3
kinase) under the control of the unc-54 or ges-1 promoters
does partially rescue the dauer phenotype of age-1 mutants
(Wolkow et al., 2000). PI3 kinase is a downstream effector
for several tyrosine kinase receptors in mammalian cells.
According to these data, further investigations should
allow to identify other DAF-18 regulated tyrosine kinase
receptors potentially implicated in dauer and lifespan
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